Imaxe de Portada

Discussion on the influence of nanoparticle characteristics in New Coronavirus Disease-19 and severe acute respiratory syndrome Coronavirus 2

<p>In the paper, why New Coronavirus Disease-19 (COVID-19) should belong to a class of protein nanoparticle and possessed ultra-small size and super-penetration capability, as well as effect of the COVID-19 characteristic on follows phenomena were discussed. (1) The difference existed on toxic...

Descrición completa

Gardado en:

Detalles Bibliográficos
Autor Principal:	Shenguo Wang (Author)
Formato:	Libro
Publicado:	International Journal of Nanomaterials, Nanotechnology and Nanomedicine - Peertechz Publications, 2021-03-31.
Subjects:	Review Article
Acceso en liña:	Connect to this object online.
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares

New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019
por: Regine J. Mathieu, MD, et al.
Publicado: (2020)

Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)
por: Su Eun Park
Publicado: (2020)

Response to "New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019"
por: Florence Assan, MSc, et al.
Publicado: (2021)

Several peripheral blood cells and the infection of sever acute respiratory syndrome coronavirus 2
por: Jianwei Zhou, et al.
Publicado: (2020)

Severe acute respiratory syndrome (SARS) related coronavirus in bats
por: Rong Geng, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge
por: Sambit K. Mohanty, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
por: Federica Mannino, et al.
Publicado: (2020)

Coronavirus disease-19 (severe acute respiratory syndrome-coronavirus-2) is not just simple influenza: What have we learned so far?
por: Ali M Somily, et al.
Publicado: (2020)

Dentistry vs Severe Acute Respiratory Syndrome Coronavirus 2: How to face this enemy
por: Marcelo Henrique NAPIMOGA, et al.
Publicado: (2020)

Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review
por: Xiujuan Tang, et al.
Publicado: (2021)

A Review of Severe Acute Respiratory Syndrome Coronavirus 2 and Pathological Disorders in Patients
por: Ghorbat Saleh Ali, et al.
Publicado: (2021)

Prevalence of severe acute respiratory syndrome coronavirus 2 in the saliva of individuals with coronavirus disease 2019: A cross-sectional study
por: Nara Santos Araujo, et al.
Publicado: (2023)

Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
por: Nabab Khan, et al.
Publicado: (2020)

Pathogenesis, immune response and laboratory diagnosis of severe acute respiratory syndrome associated Coronavirus 2
por: Deepa Revi
Publicado: (2020)

Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection
por: Shadi Khalil, MD, PhD, et al.
Publicado: (2020)

The Role of Ubiquitin-Proteasome System in the Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus-2 Disease
por: Fikadu Seyoum Tola
Publicado: (2023)

Pulmonary Surfactant: possible intervention against the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Elaine Díaz Casañas, et al.
Publicado: (2020)

Association of HLA class I with severe acute respiratory syndrome coronavirus infection
por: Lim Ken Hong, et al.
Publicado: (2003)

Severe acute respiratory syndrome coronavirus 2 positivity in neonates born to coronavirus disease 2019-positive mothers: A retrospective data analysis
por: Shailesh Pande, et al.
Publicado: (2023)

Analysis of surface contamination of severe acute respiratory syndrome coronavirus 2 in a health-care setting in the context of the coronavirus disease-2019 pandemic
por: Amrish Kohli, et al.
Publicado: (2022)

Incubation Period of Severe Acute Respiratory Syndrome Novel Coronavirus 2 that Causes Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Gizachew Tadesse Wassie, MPH, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody: Seroprevalence among contacts of COVID-19 cases
por: Om Prakash, et al.
Publicado: (2021)

Challenges and complexities in evaluating severe acute respiratory syndrome coronavirus 2 molecular diagnostics during the COVID-19 pandemic
por: Lesley E. Scott, et al.
Publicado: (2022)

Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19
por: Rebecca N. Bauer, et al.
Publicado: (2023)

A review on human reproductive systems encountering with the severe acute respiratory syndrome coronavirus 2 infection
por: Esmaeil Samadian, et al.
Publicado: (2023)

Prevalence of severe acute respiratory syndrome coronavirus 2 spike antibodies in some healthcare settings in Egypt
por: Engy Mohamed El-Ghitany, et al.
Publicado: (2022)

Response to a cluster of Severe Acute Respiratory Syndrome Coronavirus 2 cases at a diagnostic laboratory
por: Christoffel J. Opperman, et al.
Publicado: (2020)

Impact of the Severe acute respiratory syndrome coronavirus 2 pandemic on mortality associated with healthcare-associated infections
por: Andrew Atkinson, et al.
Publicado: (2023)

Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia
por: Young Shil Park
Publicado: (2021)

2020 Updates on tocilizumab indications for clinicians managing patients with severe acute respiratory syndrome coronavirus 2
por: Mohammed A Omair, et al.
Publicado: (2020)

Rapid Antigen Detection Test for Severe Acute Respiratory Syndrome Coronavirus 2: How to Use It Properly?
por: Tonny Loho, et al.
Publicado: (2021)

Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Chao Zhang, et al.
Publicado: (2020)

Individualizing dialysis dose under certain circumstances during the Severe Acute Respiratory Syndrome Coronavirus-2 (coronavirus disease 2019) pandemic: a perspective
por: Tarek Samy Abdelaziz
Publicado: (2020)

Environmental severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contamination in hospital rooms during the first and third coronavirus disease 2019 (COVID-19) waves
por: Killian Le Neindre, et al.
Publicado: (2022)

Therapeutic approaches against coronaviruses acute respiratory syndrome
por: Camilla Servidio, et al.
Publicado: (2021)

Acute tubulointerstitial nephritis in 10-year-old boy following severe acute respiratory syndrome coronavirus 2 infection
por: Aleksandra Sobieszczańska-Droździel, et al.
Publicado: (2021)

Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection
por: Ivelina Trifonova, et al.
Publicado: (2022)

Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Nicholas D. Brownstone, et al.
Publicado: (2020)

Is ventilation in grocery stores adequate to minimize the risk for airborne transmission of severe acute respiratory syndrome coronavirus 2?
por: Maria M. Torres-Teran, et al.
Publicado: (2022)

The Environmental Deposition of Severe Acute Respiratory Syndrome Coronavirus 2 in Nosocomial Settings: Role of the Aerosolized Hydrogen Peroxide
por: Alnimr A, et al.
Publicado: (2021)